PDS Biotechnology (PDSB) has entered into securities purchase agreements with new and existing healthcare focused institutional investors as ...

PDS Biotechnology (PDSB) announced the publication of clinical results in the Journal of the American Medical Association, JAMA, Oncology. The ...

HC Wainwright restated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a research note released on Monday morning,Benzinga reports. The brokerage currently has a $ ...

50% of patients PRINCETON, N.J., Feb. 20, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused ...

The Super Bowl logo has become more of a talking point among NFL fans over the last few seasons. Part of the reason for that is a conspiracy theory that the colors of the Super Bowl logo determine ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

PDS Biotechnology Corporation (NASDAQ:PDSB) stock has reached a 52-week low, trading at $1.3, as investors navigate a tumultuous market environment. According to InvestingPro analysis, the stock ...

On Monday, three logos were revealed to the public, one for each potential nickname, but NHL fans weren't particularly impressed by the latest round of options. Much of the criticism was focused ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...